During the past decade, Klinikum Hoyerswerda conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Hoyerswerda" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Hoyerswerda" are "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Klinikum Hoyerswerda" in a lesser frequency.

Most popular intervention types in "Klinikum Hoyerswerda" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apabetalone" (1 trials), "Atorvastatin" (1 trials), "Cardiac resynchronisation therapy" (1 trials), "Implantable cardioverter-defibrillator" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Hoyerswerda" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Hoyerswerda". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Hoyerswerda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Hoyerswerda, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".